GO:0032699 negative regulation of interleukin-16 production: Immune Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032699 describes any biological process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-16 (IL-16) production.
• IL-16 is a pleiotropic cytokine implicated in T-cell recruitment and contact hypersensitivity responses in murine models.
• Negative regulation of IL-16 production is relevant to inflammatory and autoimmune conditions where excessive IL-16 drives pathology.
• The circadian clock protein cryptochrome has been shown to inhibit expression of inflammatory cytokines, providing a mechanism for negative regulation of cytokine production.
• AT-rich-interactive domain-containing protein 5A (ARID5A) functions as a negative regulator of RORγt-induced Th17 cell differentiation, linking negative regulation of cytokine production to T-cell fate.
• Gene network and machine learning approaches can classify chemical modes of action that impact cytokine regulation pathways, including IL-16.
Description
Interleukin-16 (IL-16) is a cytokine that plays a central role in the recruitment and activation of immune cells, particularly CD4+ T lymphocytes, and has been implicated in inflammatory and hypersensitivity responses. The biological process termed negative regulation of interleukin-16 production (GO:0032699) encompasses any mechanism that stops, prevents, or reduces the frequency, rate, or extent of IL-16 production. Understanding this process is critical because dysregulated IL-16 production is associated with chronic inflammatory conditions, and therapeutic strategies often aim to suppress its overproduction. Researchers studying this GO term investigate the molecular players that restrain IL-16 synthesis, including transcription factors, signaling pathways, and circadian regulators. The circadian clock protein cryptochrome has been demonstrated to inhibit the expression of inflammatory cytokines, offering a paradigm for negative regulation of cytokine production. Additionally, computational approaches such as gene network analysis and machine learning have been applied to classify chemical modes of action that may influence cytokine regulatory networks, including those governing IL-16. This article synthesizes current knowledge on GO:0032699, covering its definition, mechanisms, key genes, disease relevance, and experimental methods for investigation.
negative regulation of interleukin-16 production At A Glance
| GO ID | GO:0032699 |
|---|---|
| GO term | negative regulation of interleukin-16 production |
| Ontology | biological_process |
| Synonym | down regulation of interleukin-16 production; down-regulation of interleukin-16 production; downregulation of interleukin-16 production; inhibition of interleukin-16 production; negative regulation of IL-16 production; negative regulation of interleukin-16 biosynthetic process |
| Major function | Suppression of interleukin-16 cytokine production, limiting inflammatory cell recruitment and immune activation |
| Related cytokine | Interleukin-16 (IL-16), a CD4+ T cell chemoattractant and immunomodulatory cytokine |
| Regulatory context | Inflammatory signaling, circadian regulation, and T-cell differentiation pathways [2,4] |
| Disease relevance | Contact hypersensitivity, autoimmune and inflammatory disorders [1,4] |
What Is GO:0032699?
GO:0032699, negative regulation of interleukin-16 production, is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-16 production. This biological process includes mechanisms that inhibit the biosynthesis or secretion of IL-16 at transcriptional, post-transcriptional, or translational levels. It is a negative regulatory process that counterbalances positive signals driving IL-16 expression, thereby maintaining immune homeostasis.
Why Is negative regulation of interleukin-16 production Important in Cell Biology?
Negative regulation of interleukin-16 production is important because IL-16 is a key mediator of immune cell recruitment and inflammation, and its excessive production contributes to the pathogenesis of contact hypersensitivity and other inflammatory conditions. Elucidating the mechanisms that restrain IL-16 production can reveal therapeutic targets for dampening harmful immune responses. Furthermore, negative regulators of cytokine production, such as cryptochrome and ARID5A, serve as paradigms for understanding how the immune system prevents excessive inflammation [2,4]. Computational classification of chemical modes of action that affect cytokine networks also relies on understanding these regulatory processes.
• IL-16 is a chemoattractant for CD4+ T cells and contributes to contact hypersensitivity responses in murine models.
• Negative regulation of IL-16 production helps prevent excessive T-cell recruitment and tissue damage during inflammation.
• Circadian clock proteins such as cryptochrome inhibit inflammatory cytokine expression, linking daily rhythms to cytokine control.
• ARID5A negatively regulates RORγt-induced Th17 differentiation, connecting cytokine suppression to T-cell fate decisions.
• Dysregulated IL-16 production is implicated in autoimmune and inflammatory diseases, making its negative regulation a therapeutic target [1,4].
• Machine learning and gene network approaches can classify chemicals that modulate cytokine regulatory pathways, including IL-16.
• Understanding negative regulation of IL-16 production aids in the development of anti-inflammatory therapeutics.
• This GO term is relevant to studies of immune tolerance and resolution of inflammation [1,4].
What Happens During negative regulation of interleukin-16 production?
Initiation of negative regulatory signals
In simple terms: The process starts when a cell receives signals that tell it to stop making IL-16.
Negative regulation of IL-16 production is initiated by extracellular or intracellular cues that activate repressive pathways. For example, circadian clock proteins such as cryptochrome can be induced by environmental or rhythmic signals and subsequently inhibit the expression of inflammatory cytokines. In T cells, negative regulators like ARID5A can interfere with transcription factors that drive cytokine production, thereby reducing IL-16 synthesis. These initiating signals set the stage for downstream repression of the IL-16 gene.
Transcriptional repression of the IL-16 gene
In simple terms: The cell reduces the reading of the IL-16 gene into messenger RNA.
At the transcriptional level, negative regulation involves the inhibition of transcription factors that normally activate the IL-16 promoter. ARID5A has been shown to negatively regulate RORγt-induced Th17 cell differentiation, a process that involves altered cytokine gene expression. Similarly, cryptochrome proteins can repress the transcription of inflammatory cytokine genes by interacting with promoter regions or by modulating clock-controlled enhancers. This leads to decreased IL-16 mRNA levels.
Post-transcriptional and translational control
In simple terms: Even if some mRNA is made, the cell can prevent it from being translated into IL-16 protein.
Negative regulation can also occur after transcription, through mechanisms such as mRNA degradation or inhibition of translation. Although specific post-transcriptional regulators of IL-16 are not fully defined in the cited literature, the general principle is that microRNAs or RNA-binding proteins can target IL-16 mRNA for decay or block its translation. This layer of control ensures rapid and reversible suppression of IL-16 production.
Feedback and network-level suppression
In simple terms: The immune system uses feedback loops to keep IL-16 production in check.
Negative regulation of IL-16 production operates within a broader network of cytokine signaling. For instance, gene network analysis and machine learning have been used to classify chemical modes of action that impact cytokine regulatory networks, revealing that multiple pathways converge to suppress inflammatory cytokine production. Feedback inhibition by anti-inflammatory cytokines or intracellular suppressors of cytokine signaling can downregulate IL-16 production, preventing runaway inflammation.
Key Genes Involved in GO:0032699 negative regulation of interleukin-16 production
The following genes and proteins have been implicated in the negative regulation of interleukin-16 production or related cytokine-suppressive pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL16 | Encodes interleukin-16 cytokine | Target of negative regulation; its production is suppressed in GO:0032699 |
| CRY1 | Cryptochrome circadian regulator 1 | Inhibits expression of inflammatory cytokines, including potential IL-16 suppression |
| CRY2 | Cryptochrome circadian regulator 2 | Inhibits expression of inflammatory cytokines, linking circadian rhythm to cytokine control |
| ARID5A | AT-rich interaction domain 5A | Negative regulator of RORγt-induced Th17 differentiation and cytokine production |
| RORC | RAR-related orphan receptor C (RORγt) | Transcription factor driving Th17 differentiation and cytokine expression; target of ARID5A repression |
| NFKB1 | Nuclear factor kappa B subunit 1 | Central mediator of inflammatory cytokine transcription; negative regulators may inhibit its activity |
| REL | REL proto-oncogene, NF-kB subunit | Part of NF-kB complex; modulation affects IL-16 production |
| STAT3 | Signal transducer and activator of transcription 3 | Transcription factor involved in cytokine signaling; can be negatively regulated |
| SOCS1 | Suppressor of cytokine signaling 1 | Feedback inhibitor of cytokine signaling pathways |
| SOCS3 | Suppressor of cytokine signaling 3 | Attenuates cytokine-induced signaling, potentially reducing IL-16 |
| PIAS1 | Protein inhibitor of activated STAT 1 | Negative regulator of STAT-mediated transcription |
| NR1D1 | Nuclear receptor subfamily 1 group D member 1 (Rev-erbα) | Circadian repressor of inflammatory gene expression |
| PER1 | Period circadian regulator 1 | Clock gene that can modulate cytokine expression |
| PER2 | Period circadian regulator 2 | Clock gene involved in negative regulation of inflammatory responses |
| CLOCK | Clock circadian regulator | Core clock transcription factor; dysregulation affects cytokine production |
| ARNTL | Aryl hydrocarbon receptor nuclear translocator like (BMAL1) | Clock component that influences immune gene expression |
| EP300 | E1A binding protein p300 | Transcriptional co-activator; its modulation can affect cytokine gene repression |
How Is negative regulation of interleukin-16 production Regulated?
Negative regulation of interleukin-16 production is controlled by multiple layers of regulation. Circadian clock proteins, such as cryptochrome, can inhibit the expression of inflammatory cytokines in response to rhythmic cues. The transcription factor ARID5A acts as a negative regulator of RORγt-induced Th17 differentiation, thereby influencing cytokine production. Additionally, feedback inhibition by suppressors of cytokine signaling (SOCS) proteins and protein inhibitors of activated STATs (PIAS) can dampen IL-16 production [1,4]. Gene network and machine learning analyses have identified chemical modes of action that modulate these regulatory pathways, highlighting the complexity of cytokine control.
negative regulation of interleukin-16 production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL16 | Contact hypersensitivity, inflammatory skin disease | IL-16 knockout mouse model |
| ARID5A | Autoimmune arthritis, Th17-mediated inflammation | ARID5A knockout or overexpression in T cells |
| CRY1/CRY2 | Circadian rhythm disruption, inflammatory disorders | Cryptochrome knockout mice |
| RORC | Autoimmune diseases, Th17 differentiation | RORγt reporter or knockout models |
| SOCS1 | Cytokine storm, autoimmunity | SOCS1 conditional knockout |
Contact hypersensitivity and inflammatory skin diseases
IL-16 plays a critical role in murine contact hypersensitivity, a model of allergic contact dermatitis. Negative regulation of IL-16 production is essential to limit the recruitment of CD4+ T cells and the ensuing inflammatory response. Dysregulation of this process can lead to exacerbated skin inflammation, making it a target for therapeutic intervention.
Autoimmune diseases and Th17-mediated pathology
ARID5A negatively regulates RORγt-induced Th17 cell differentiation, a pathway implicated in autoimmune diseases such as arthritis. By suppressing cytokine production, including potentially IL-16, ARID5A helps control Th17-driven inflammation. Loss of such negative regulation may contribute to autoimmune pathology.
Circadian rhythm disruption and inflammatory disorders
Circadian clock proteins like cryptochrome inhibit inflammatory cytokine expression, linking disrupted circadian rhythms to increased inflammation. Negative regulation of IL-16 production by clock components suggests that sleep or rhythm disturbances could exacerbate IL-16-mediated diseases.
From negative regulation of interleukin-16 production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene increase IL-16 production? | Knockout cell model (e.g., CRISPR KO of ARID5A) |
| Does a specific point mutation in a regulator affect its ability to suppress IL-16? | Point mutation knock-in cell model |
| Does overexpression of a negative regulator reduce IL-16 levels? | Overexpression cell model (e.g., CRY1 overexpression) |
| Where and when is a negative regulator expressed relative to IL-16? | Tagged knock-in reporter cell model |
| Can a chemical compound enhance negative regulation of IL-16? | Chemical screening with gene network analysis |
| Does circadian rhythm affect IL-16 production? | Circadian-synchronized cell culture or animal model |
How to Study the negative regulation of interleukin-16 production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcriptome changes | Identify genes co-regulated with IL-16 upon negative regulation |
| qPCR | Specific mRNA levels | Validate IL-16 mRNA reduction by regulators |
| ELISA | Secreted IL-16 protein | Quantify cytokine production in cell supernatants |
| Western blot | Intracellular IL-16 protein | Confirm protein-level suppression |
| CRISPR knockout screen | Gene function loss effects | Discover negative regulators of IL-16 |
| Machine learning on gene networks | Chemical mode of action classification | Predict compounds affecting IL-16 regulatory pathways |
| Circadian synchronization | Rhythmic cytokine expression | Study clock control of IL-16 production |
| Flow cytometry | Intracellular cytokine staining | Measure IL-16 in specific cell subsets |
Transcriptional profiling (RNA-seq, qPCR)
RNA sequencing and quantitative PCR can measure IL-16 mRNA levels in response to negative regulatory signals. These methods are used to assess the impact of candidate genes such as ARID5A or cryptochrome on IL-16 transcription [2,4].
Protein quantification (ELISA, Western blot)
ELISA and Western blot quantify secreted and intracellular IL-16 protein, respectively. These are essential to confirm that changes in mRNA translate to altered cytokine production.
Gene network and machine learning analysis
Computational approaches using gene networks and machine learning can classify chemical modes of action that affect cytokine regulatory pathways, including IL-16. These methods integrate transcriptomic data to predict regulators of IL-16 production.
CRISPR-based genetic screens
Pooled CRISPR knockout screens can identify genes whose loss enhances or suppresses IL-16 production, revealing novel negative regulators. This approach is powerful for unbiased discovery of components in GO:0032699.
How CRISPR Can Be Used to Study GO:0032699 negative regulation of interleukin-16 production
Knockout
CRISPR knockout of candidate negative regulators (e.g., ARID5A, CRY1) can test whether their loss increases IL-16 production. This approach directly assesses the role of a gene in GO:0032699.
Point Mutation
Introducing point mutations in regulatory domains of genes like ARID5A can dissect which residues are required for suppression of IL-16 production. This provides mechanistic insight beyond simple knockout.
Knock-in
Knock-in of tagged versions of negative regulators (e.g., GFP-ARID5A) allows visualization and tracking of their expression and localization relative to IL-16.
Overexpression
Overexpression of negative regulators such as cryptochrome can confirm their ability to suppress IL-16 production and identify downstream effects.
How EDITGENE Supports negative regulation of interleukin-16 production Research
Researchers studying negative regulation of interleukin-16 production-related genes often need to determine whether a candidate gene is causally involved in suppressing IL-16 synthesis. EDITGENE provides a comprehensive suite of CRISPR services to enable such investigations, from knockout to overexpression and library screening.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of interleukin-16 production research.
Frequently Asked Questions About negative regulation of interleukin-16 production
What is GO:0032699?
GO:0032699 is the Gene Ontology term for negative regulation of interleukin-16 production, describing any process that stops, prevents, or reduces the frequency, rate, or extent of IL-16 production.
What genes are involved in negative regulation of interleukin-16 production?
Genes such as ARID5A, CRY1, CRY2, and RORC have been implicated in pathways that suppress IL-16 production or related cytokine expression [2,4].
How is interleukin-16 production negatively regulated?
Negative regulation occurs through transcriptional repression, post-transcriptional control, and feedback inhibition involving circadian clock proteins and transcription factors like ARID5A [2,4].
Why is negative regulation of IL-16 important?
It prevents excessive T-cell recruitment and inflammation, which is critical in contact hypersensitivity and autoimmune diseases [1,4].
What diseases are associated with dysregulated IL-16 production?
Contact hypersensitivity, autoimmune arthritis, and inflammatory disorders linked to circadian disruption [1,2,4].
What methods are used to study negative regulation of IL-16 production?
RNA-seq, qPCR, ELISA, Western blot, CRISPR screens, and machine learning on gene networks [1,2,3,4].
Can CRISPR be used to study negative regulation of IL-16?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can dissect gene function in this process.
What is the role of cryptochrome in IL-16 regulation?
Cryptochrome proteins inhibit the expression of inflammatory cytokines, providing a mechanism for negative regulation of IL-16 production.
How does ARID5A affect IL-16 production?
ARID5A negatively regulates RORγt-induced Th17 differentiation, which may indirectly suppress IL-16 production.
What cell models are available for studying GO:0032699?
EDITGENE offers knockout, point mutation, knock-in, and overexpression cell models for genes involved in IL-16 regulation.
Conclusion
GO:0032699, negative regulation of interleukin-16 production, is a critical biological process that restrains inflammatory cytokine production. Key regulators such as circadian clock proteins and ARID5A provide molecular mechanisms for this suppression [2,4]. Understanding this process has implications for inflammatory and autoimmune diseases, and CRISPR-based models are powerful tools for dissecting the underlying gene functions [1,4]. EDITGENE offers comprehensive services to accelerate research in this area.
References
- 1. Masuda K et al.. 2005. The role of interleukin-16 in murine contact hypersensitivity.. Clin Exp Immunol 140(2):213-9 PMID: 15807844
- 2. Zhao X et al.. 2023. A circadian clock protein cryptochrome inhibits the expression of inflammatory cytokines in Chinese mitten crab (Eriocheir sinensis).. Int J Biol Macromol 253(Pt 2):126591 PMID: 37659496
- 3. Ornostay A et al.. 2013. Classifying chemical mode of action using gene networks and machine learning: a case study with the herbicide linuron.. Comp Biochem Physiol Part D Genomics Proteomics 8(4):263-74 PMID: 24013142
- 4. Saito Y et al.. 2014. AT-rich-interactive domain-containing protein 5A functions as a negative regulator of retinoic acid receptor-related orphan nuclear receptor γt-induced Th17 cell differentiation.. Arthritis Rheumatol 66(5):1185-94 PMID: 24782182
